Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Anthropic, the company behind Claude AI, has warned that its artificial intelligence models could soon reach a stage where AI could become capable of ...
Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Learning and research resources for Recursive Self-Improvement (RSI). A curated directory of awesome lists, learning guides, tutorials, and courses on recursive self-improvement. This project brings ...
@gavpartygamer @mywaterbrock Check out my tutorial on recursion, you may like it! It's on my bio. I do a full explaination of it, and I think you'll find it interesting! (NO SCREENS NO AI) ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...
Are recursive ZK proofs used in ZK-rollups? Yes, recursive proofs can help ZK-rollups aggregate transaction proofs or batch proofs before final settlement on a base chain. Are recursive ZK proofs only ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.
On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results